Factors Affecting Usage Levels and Trends of Innovative Oncology Drugs Upon and After Reimbursement Under Taiwan National Health Insurance: Interrupted Time Series Analysis

por Liao, Kai‐Hsin, Ko, Bor‐Sheng, Chen, Liang‐Kung, Hsiao, Fei‐Yuan
Publicado 2020

Reimbursement Lag of New Drugs Under Taiwan's National Health Insurance System Compared With United Kingdom, Canada, Australia, Japan, and South Korea

por Shih, Yi‐Ru, Liao, Kai‐Hsin, Chen, Yen‐Hui, Lin, Fang‐Ju, Hsiao, Fei‐Yuan
Publicado 2020

Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007–2017

por Huang, Shao-Yi, Chen, Ho-Min, Liao, Kai-Hsin, Ko, Bor-Sheng, Hsiao, Fei-Yuan
Publicado 2020

Ligand-Based and Structure-Based Investigation for Alzheimer's Disease from Traditional Chinese Medicine

por Liao, Kai Hsin, Chen, Kuen-Bao, Lee, Wen-Yuan, Sun, Mao-Feng, Lee, Cheng-Chun, Chen, Calvin Yu-Chian
Publicado 2014

Comparative assessment of clinical response in patients with rheumatoid arthritis between PF‐05280586, a proposed rituximab biosimilar, and rituximab

por Williams, Jason H., Hutmacher, Matthew M., Zierhut, Matthew L., Becker, Jean‐Claude, Gumbiner, Barry, Spencer‐Green, George, Melia, Lisa A., Liao, Kai‐Hsin, Suster, Matthew, Yin, Donghua, Li, Ruifeng, Meng, Xu
Publicado 2016